JMP Securities Starts Aimmune Therapeutics (AIMT) at Market Outperform

September 26, 2016 6:33 AM EDT
Get Alerts AIMT Hot Sheet
Price: $17.19 +0.06%

Rating Summary:
    5 Buy, 0 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 14 | Down: 11 | New: 8
Trade AIMT Now!
Join SI Premium – FREE

Get daily under-the-radar research with's Stealth Growth Insider Get your 2-Wk Free Trial here.

JMP Securities initiated coverage on Aimmune Therapeutics (NASDAQ: AIMT) with a Market Outperform rating and a price target of $30.00.

For an analyst ratings summary and ratings history on Aimmune Therapeutics click here. For more ratings news on Aimmune Therapeutics click here.

Shares of Aimmune Therapeutics closed at $16.57 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

New Coverage

Related Entities

JMP Securities

Add Your Comment